BioLineRx Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for BioLineRx Ltd. (BLRX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.010.000.010.010.020.020.03
Short-Term Investments0.010.040.040.040.010.000.00
Cash & Short-Term Investments0.020.040.050.060.020.020.03
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.000.000.000.000.000.000.00
Total Current Assets0.030.050.050.060.020.030.03
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.000.00
Intangible Assets0.010.010.020.020.020.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.010.020.020.020.030.030.02
Total Assets0.040.060.080.080.050.050.06
Current Liabilities
Accounts Payable0.010.010.010.010.010.010.01
Short-Term Debt0.010.000.000.000.000.000.00
Current Portion of Long-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.000.000.000.000.000.000.00
Deferred Revenue0.000.010.000.000.000.000.00
Other Current Liabilities0.000.010.000.020.000.000.00
Total Current Liabilities0.020.040.010.010.010.010.01
Non-Current Liabilities
Long-Term Debt0.010.010.010.000.000.000.01
Other Non-Current Liabilities0.000.010.030.000.010.010.00
Total Non-Current Liabilities0.010.010.010.000.010.010.01
Total Liabilities0.030.050.030.010.030.020.01
Stockholders' Equity
Common Stock0.040.030.030.020.010.000.00
Retained Earnings-0.40-0.39-0.33-0.31-0.28-0.25-0.22
Accumulated Other Comprehensive Income0.020.020.010.010.010.010.01
Additional Paid-in Capital0.350.360.340.340.280.270.25
Shares Outstanding1.341.090.920.720.000.000.00
Total Stockholders' Equity0.010.010.050.070.020.030.04
Total Liabilities & Equity0.040.060.080.080.030.050.06